PubRank

Merrick I Ross

Author PubWeight™ 252.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009 23.08
2 Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol 2009 4.32
3 Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med 2011 3.10
4 Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 2006 2.84
5 Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010 2.83
6 Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol 2006 2.60
7 Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites. BMJ 2002 2.53
8 Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 2002 2.51
9 The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J Clin Oncol 2005 2.41
10 Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010 2.30
11 Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 2003 2.29
12 Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 2006 2.23
13 An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004 2.18
14 Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004 2.18
15 Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 2008 2.17
16 Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 2004 2.00
17 Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol 2011 1.93
18 Metastatic melanoma to lymph nodes in patients with unknown primary sites. Cancer 2006 1.93
19 Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 2007 1.92
20 Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial. Clin Cancer Res 2009 1.90
21 Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res 2012 1.90
22 Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 2009 1.89
23 Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 2006 1.85
24 Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J Am Coll Surg 2003 1.81
25 Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 2010 1.80
26 Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol 2011 1.78
27 Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol 2005 1.76
28 A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 2009 1.76
29 Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 2003 1.74
30 Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 2008 1.71
31 Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg 2002 1.70
32 Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 2006 1.70
33 Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 2006 1.70
34 Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 2008 1.67
35 Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol 2002 1.65
36 Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol 2003 1.64
37 Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 2006 1.63
38 Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer 2009 1.63
39 Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002 1.62
40 Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol 2004 1.61
41 Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005 1.61
42 Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients. Ann Surg Oncol 2002 1.57
43 Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer 2007 1.54
44 p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol 2003 1.54
45 Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer 2010 1.53
46 Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 2004 1.52
47 Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003 1.52
48 Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. J Clin Oncol 2006 1.50
49 Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 2005 1.50
50 Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine. J Clin Oncol 2011 1.46
51 Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 2002 1.45
52 Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003 1.45
53 Melanoma, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2013 1.44
54 Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 2003 1.42
55 Breast cancer in reduction mammaplasty specimens: case reports and guidelines. Breast J 2003 1.41
56 A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg 2009 1.39
57 Melanoma. J Natl Compr Canc Netw 2009 1.37
58 New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 2003 1.34
59 A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol 2002 1.33
60 Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. Am J Surg 2003 1.33
61 Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 2007 1.32
62 Interval sentinel lymph nodes in melanoma. Arch Surg 2002 1.32
63 Gender-related differences in outcome for melanoma patients. Ann Surg 2006 1.32
64 Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst 2010 1.31
65 Biochemotherapy in patients with metastatic anorectal mucosal melanoma. Cancer 2004 1.30
66 Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 2004 1.29
67 The role of adjuvant radiotherapy in the local management of desmoplastic melanoma. Cancer 2013 1.28
68 Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease. Ann Surg Oncol 2010 1.24
69 Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer 2010 1.19
70 The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer 2004 1.18
71 Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 2006 1.18
72 Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer 2004 1.18
73 Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications. J Cutan Pathol 2007 1.16
74 Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol 2010 1.16
75 Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 2004 1.16
76 Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 2004 1.15
77 Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer 2006 1.15
78 Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 2005 1.14
79 Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 2005 1.12
80 Melanoma adrenal metastasis: natural history and surgical management. Am J Surg 2008 1.10
81 Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 2012 1.10
82 How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer 2008 1.10
83 Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev 2006 1.10
84 Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma. Carcinogenesis 2006 1.09
85 Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol 2003 1.08
86 Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol 2009 1.08
87 Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma. J Clin Oncol 2011 1.07
88 Metastasectomy for stage IV melanoma: for whom and how much? Surg Oncol Clin N Am 2011 1.07
89 Melanoma, version 4.2014. J Natl Compr Canc Netw 2014 1.07
90 Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg 2007 1.05
91 Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg 2011 1.05
92 Cost effectiveness of adjuvant interferon in node-positive melanoma. J Clin Oncol 2007 1.05
93 Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 2006 1.05
94 Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience. Cancer 2011 1.04
95 Breast conservation after neoadjuvant chemotherapy. Cancer 2005 1.04
96 Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer 2004 1.03
97 Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis. Ann Surg Oncol 2009 1.03
98 Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016 1.02
99 Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 2002 1.02
100 Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 2002 1.02
101 A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma. Cancer 2009 1.01
102 Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics 2006 1.00
103 Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years. Carcinogenesis 2006 1.00
104 Reconstruction following radical resection of recurrent metastatic axillary melanoma. Plast Reconstr Surg 2006 0.99
105 Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma. Cancer 2002 0.99
106 Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire. Cancer 2008 0.98
107 Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy. Ann Surg 2013 0.97
108 Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J Invest Dermatol 2006 0.97
109 Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol 2011 0.97
110 Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg 2010 0.96
111 Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003 0.96
112 Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer 2005 0.96
113 Paget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 2005 0.95
114 Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer. Ann Surg Oncol 2011 0.95
115 Is incisional biopsy of melanoma harmful? Am J Surg 2005 0.94
116 Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 2008 0.94
117 Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer 2010 0.94
118 Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg 2006 0.93
119 Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology 2009 0.93
120 Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy. Clin Cancer Res 2011 0.93
121 Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Ann Surg Oncol 2007 0.93
122 Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights. Value Health 2011 0.93
123 Extensive pigmented villonodular synovitis with markedly pigmented lymphadenopathy and its implication for differential diagnosis with malignant melanoma. Ann Diagn Pathol 2003 0.92
124 Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Mod Pathol 2013 0.92
125 In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst 2005 0.92
126 Second primary melanomas: incidence and outcome. Am Surg 2010 0.92
127 Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol 2014 0.91
128 Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311). World J Surg Oncol 2008 0.90
129 Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg 2011 0.90
130 Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol 2013 0.90
131 Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer 2010 0.90
132 Melanoma. J Natl Compr Canc Netw 2012 0.90
133 Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys 2005 0.90
134 PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. AJR Am J Roentgenol 2012 0.90
135 Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer J 2002 0.89
136 Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. Am J Surg 2004 0.89
137 Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg 2004 0.89
138 DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2002 0.89
139 The prognostic significance of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2010 0.88
140 Adjuvant irradiation for axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 2002 0.88
141 Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma. J Transl Med 2010 0.87
142 Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg 2006 0.87
143 Prognostic information from sentinel lymph node biopsy in patients with thick melanoma. Arch Surg 2010 0.87
144 Implications of axillary sentinel lymph node biopsy in immediate autologous breast reconstruction. Plast Reconstr Surg 2002 0.87
145 Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer 2004 0.87
146 Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer 2006 0.86
147 Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective? Cancer 2006 0.86
148 Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. Am Surg 2011 0.86
149 Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer 2003 0.85
150 Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma. Ann Surg Oncol 2014 0.85
151 Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma. Cancer 2006 0.85
152 Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer 2004 0.84
153 Effect of multiple-nodal basin drainage on cutaneous melanoma. Arch Surg 2008 0.84
154 Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review. Melanoma Res 2012 0.84
155 Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 2007 0.83
156 Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer 2004 0.83
157 A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence. Melanoma Res 2009 0.83
158 Melanoma. J Natl Compr Canc Netw 2006 0.83
159 The palliative index: predicting outcomes of emergent surgery in patients with cancer. J Palliat Med 2014 0.83
160 Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies. Ann Surg 2014 0.83
161 Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 2005 0.83
162 Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer 2006 0.83
163 Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cancer 2004 0.83
164 Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg 2006 0.82
165 Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease? Head Neck 2005 0.82
166 Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma. J Transl Med 2010 0.82
167 A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Ann Surg Oncol 2004 0.82
168 Isolated limb perfusion for unresectable extremity sarcoma: results of 2 single-institution phase 2 trials. Cancer 2011 0.82
169 Pneumoperitoneum in the cancer patient. Ann Surg Oncol 2007 0.81
170 Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. J Am Coll Surg 2005 0.81
171 Breast-conservation therapy in early-stage breast cancer patients with a positive family history. Ann Surg Oncol 2002 0.81
172 Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat 2003 0.80
173 Bilateral anterolateral thigh flaps for large-volume breast reconstruction. Microsurgery 2004 0.80
174 Conjunctival melanoma with a positive sentinel lymph node. Arch Ophthalmol 2003 0.80
175 Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma. Melanoma Res 2013 0.80
176 Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease. Cancer 2008 0.80
177 Do melanoma patients from Southern climates have a worse outcome than those from Northern climates? Am Surg 2009 0.80
178 Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 2008 0.80
179 Diversity of stage III melanoma in the era of sentinel lymph node biopsy. Ann Surg Oncol 2012 0.79
180 Surveillance after surgical treatment of melanoma: futility of routine chest radiography. Surgery 2010 0.79
181 Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer 2008 0.79
182 Lymphatic mapping in the molecular era. Ann Surg Oncol 2004 0.79
183 The relationship between blood IL-12p40 level and melanoma progression. Int J Cancer 2014 0.78
184 Reducing patient burden to the FACT-Melanoma quality-of-life questionnaire. Melanoma Res 2012 0.78
185 Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. J Surg Res 2007 0.78
186 Surgery for inoperable breast cancer. Am J Surg 2002 0.78
187 A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model. J Am Coll Surg 2012 0.78
188 Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int J Radiat Oncol Biol Phys 2004 0.78
189 Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy. Clin Nucl Med 2005 0.78
190 Impact of sentinel lymph node biopsy on the evolution of breast reconstruction. Plast Reconstr Surg 2006 0.78
191 Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node. Am J Surg 2005 0.77
192 Sentinel lymph node dissection is technically feasible in older breast cancer patients. Clin Breast Cancer 2010 0.77
193 Is sentinel-node biopsy superior to nodal observation in melanoma? Nat Clin Pract Oncol 2007 0.76
194 Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study. Melanoma Res 2015 0.76
195 Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark. Eur J Surg Oncol 2005 0.75
196 Health-related quality of life in patients with melanoma: overview of instruments and outcomes. Dermatol Clin 2011 0.75
197 Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma. AJR Am J Roentgenol 2006 0.75
198 The role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the breast. Breast J 2006 0.75
199 COUNTERPOINT: Surgical Management of Lymph Node Basin in Sentinel Lymph Node-Positive Melanoma. Oncology (Williston Park) 2016 0.75
200 An opportunity to ensure high-quality melanoma care through the use of a preoperative treatment algorithm. Ann Surg Oncol 2013 0.75
201 Sentinel lymph node dissection in early stage breast cancer. Breast Cancer 2002 0.75
202 Innovations and challenges in melanoma: summary statement from the first Cambridge conference. Clin Cancer Res 2006 0.75
203 Interferon-alpha in high-risk melanoma patients. Expert Rev Pharmacoecon Outcomes Res 2004 0.75